Literature DB >> 16108822

Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.

Iris Bellinghausen1, Bettina König, Ingo Böttcher, Jürgen Knop, Joachim Saloga.   

Abstract

Regulatory CD4+ CD25+ FoxP3-positive T cells (Treg) are functional in most atopic patients with allergic rhinitis and are able to inhibit T helper type 1 (Th1) and Th2 cytokine production of CD4+ CD25- T cells. This study was designed to analyse the following additional aspects: influence of allergen concentration, influence of the type of allergen, and influence of the atopy status of the donor on the strength of the regulatory activity. CD4+ CD25- T cells from healthy non-atopic controls or from grass-pollen-allergic or wasp-venom-allergic donors were stimulated alone or in the presence of Treg with autologous mature monocyte-derived dendritic cells which were pulsed with different concentrations of the respective allergens. Treg from grass-pollen-allergic donors failed to inhibit proliferation but not cytokine production of CD4+ CD25- T cells at high antigen doses while Treg from non-atopic donors did not fail at these allergen concentrations. Proliferative responses and cytokine production of CD4+ CD25- T cells from most of the examined wasp-venom-allergic patients were not inhibited at any concentration of wasp venom. The use of wasp venom- or phospholipase A2-pulsed dendritic cells for stimulation of CD4+ CD25- T cells from donors who were not allergic to wasp stings only resulted in an inhibited proliferation and Th2 cytokine production by Treg at 10-fold lower than the optimal concentration, while interferon-gamma production was inhibited at all concentrations investigated. These data demonstrate that in allergic diseases the function of Treg is dependent on the concentration and the type of the respective allergen with different thresholds for individual allergens and patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108822      PMCID: PMC1802407          DOI: 10.1111/j.1365-2567.2005.02205.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Authors:  M Itoh; T Takahashi; N Sakaguchi; Y Kuniyasu; J Shimizu; F Otsuka; S Sakaguchi
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.

Authors:  Marek Jutel; Mübeccel Akdis; Ferah Budak; Carmen Aebischer-Casaulta; Maria Wrzyszcz; Kurt Blaser; Cezmi A Akdis
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

3.  T regulatory cells 1 inhibit a Th2-specific response in vivo.

Authors:  F Cottrez; S D Hurst; R L Coffman; H Groux
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

4.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery.

Authors:  Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

6.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

Authors:  James N Francis; Stephen J Till; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

Review 8.  Regulatory T cells control the development of allergic disease and asthma.

Authors:  Dale T Umetsu; Omid Akbari; Rosemarie H Dekruyff
Journal:  J Allergy Clin Immunol       Date:  2003-09       Impact factor: 10.793

9.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  9 in total

Review 1.  [Mechanisms of specific immunotherapy].

Authors:  I Bellinghausen; J Knop; J Saloga
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

2.  Increased gene expression of inflammatory markers in nasal turbinate of patients with persistent allergic rhinitis and chronic obstruction.

Authors:  Lucila de Campos; Clóvis Eduardo Santos Galvão; Eliane Conti Mairena; Richard Voegels; Jorge Kalil; Fábio Morato Castro; Edécio Cunha-Neto
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-30       Impact factor: 2.503

3.  Rhynchophylline Attenuates Tourette Syndrome via BDNF/NF-κB Pathway In Vivo and In Vitro.

Authors:  Hongyan Long; Jie Ruan; Mengjiao Zhang; Chunyan Wang; Yaruo Huang
Journal:  Neurotox Res       Date:  2019-06-26       Impact factor: 3.911

Review 4.  Current Strategies to Modulate Regulatory T Cell Activity in Allergic Inflammation.

Authors:  Iris Bellinghausen; Rahul Khatri; Joachim Saloga
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

5.  Regulatory T cells in prenatal blood samples: variability with pet exposure and sensitization.

Authors:  Ganesa Wegienka; Suzanne Havstad; Edward M Zoratti; Kimberley J Woodcroft; Kevin R Bobbitt; Dennis R Ownby; Christine Cole Johnson
Journal:  J Reprod Immunol       Date:  2009-07       Impact factor: 4.054

6.  The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.

Authors:  J-H Lee; H-H Yu; L-C Wang; Y-H Yang; Y-T Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

7.  House dust allergy and immunotherapy.

Authors:  Wayne R Thomas
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

8.  Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis.

Authors:  Alicja Majewska; Małgorzata Gajewska; Kourou Dembele; Henryk Maciejewski; Adam Prostek; Michał Jank
Journal:  BMC Vet Res       Date:  2016-08-23       Impact factor: 2.741

9.  Inhaled corticosteroid use is associated with increased circulating T regulatory cells in children with asthma.

Authors:  Anne Marie Singh; Paul Dahlberg; Kristjan Burmeister; Michael D Evans; Ronald Gangnon; Kathy A Roberg; Christopher Tisler; Douglas Dasilva; Tressa Pappas; Lisa Salazar; Robert F Lemanske; James E Gern; Christine M Seroogy
Journal:  Clin Mol Allergy       Date:  2013-01-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.